Connecticut's Record Sales In December
Connecticut experienced a record-breaking December in 2023, with combined sales of adult-use cannabis and medical marijuana surpassing $27.5 million.
The state reported this marked the highest single-month total since the market opened.
The adult-use market alone contributed over $17.1 million. Since January 10, 2023, when adult-use sales began, the state has seen a cumulative total of $274 million in sales.
Maryland's Surging Sales Post-Legalization
In Maryland, following the legalization of recreational cannabis, sales have skyrocketed, reaching nearly $700 million annually.
The increase is significant in both medical and adult-use sales, with the latter jumping from a few hundred dollars to over $270 million.
Maine's Expanding Market
Maine's regulated adult-use cannabis market generated over $200 million in sales last year, marking a 36% increase from 2022. Despite this growth, some business owners express concerns over market saturation.
The state recorded about 3.7 million transactions in 2022, totaling around $217 million, a notable rise from the $159 million in 2021 sales.
Insights for 2024
Maryland's cannabis market, especially after the legalization of recreational use, has demonstrated a remarkable surge. In October alone, sales reached $90 million, indicating a strong consumer base and a robust market. The split between medical and recreational sales ($35 million and $55 million respectively) highlights the diversified demand.
Companies like Ascend Wellness Holdings AAWHand iAnthus Capital Holdings ITHUF have reported significant revenue increases, a clear testament to the market's potential. Maryland's market, with total sales reaching $270 million in Q3 2023, offers a lucrative opportunity for investors, especially in multi-state operators with significant sales in the state.
Pablo Zuanic, a senior sector analyst, noted that some of the companies that will benefit from Maryland's cannabis market are Curaleaf CURLF, Green Thumb Industries GTBIF, TerrAscend TRSSF, Verano VRNOF, Columbia Care CCHWF, iAnthus ITHUF, Trulieve TCNNF, MariMed MRMD.
Meanwhile, Connecticut's cannabis market shows a steady upward trajectory, with sales nearing $25 million in October 2023. The balance between adult use and medical sales reflects a stable and growing market.
Investors should note the product distribution statistics, indicating consumer preferences, with over half of the sales in flower products.
The state's collection of $3.5 million in cannabis taxes in Q2 2023, a notable increase from Q1, further underscores the market's growth potential. However, issues like limited testing lab capacity could pose challenges, necessitating a watchful approach from investors.
Finally, Maine's market is showing impressive growth, with record-breaking sales in August nearing $22 million.
The consistent increase in sales, reaching $140.1 million year-to-date in 2023, suggests a strong and expanding market. However, concerns of market saturation must be considered. The high number of transactions and the dominance of flower products in sales indicate a thriving consumer market, offering diverse opportunities for investors.
Photo: AI-Generated Image.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.